Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21507,774,0.99 [0.85-1.14],0.8681832417226565
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21513,123,1.20 [0.89-1.61],0.2308290621733328
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22856,126,0.80 [0.53-1.21],0.2832068407902759
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17025,431,0.88 [0.71-1.09],0.2467458601024018
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22804,74,0.89 [0.54-1.47],0.6477745946218385
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22193,69,1.02 [0.64-1.62],0.9485845511700776
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23675,73,0.88 [0.52-1.46],0.61533045148773
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23694,49,0.87 [0.47-1.63],0.6644828495580992
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21716,40,0.60 [0.26-1.40],0.2394786586490501
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23255,93,1.11 [0.77-1.61],0.5728838816300723
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23221,59,1.06 [0.65-1.72],0.8080720443701549
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23732,57,0.53 [0.25-1.10],0.0893832669378047
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23692,92,0.87 [0.55-1.37],0.5455072890270004
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23684,84,0.86 [0.53-1.40],0.5540429642251983
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,23527,43,1.44 [0.99-2.08],0.0533324373001522
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22977,325,0.91 [0.72-1.15],0.4335976256752709
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22771,119,0.68 [0.43-1.09],0.1085554058990852
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22863,211,0.90 [0.67-1.21],0.4797808678853941
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20578,27,1.05 [0.51-2.15],0.9001140830286852
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20593,42,0.40 [0.16-1.00],0.0507128270643211
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20660,109,0.96 [0.65-1.42],0.8373444105031265
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20665,114,0.97 [0.66-1.42],0.8617299379954193
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11567,255,0.91 [0.70-1.18],0.4943108350342003
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9260,21,0.58 [0.18-1.91],0.3717177505076926
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20594,43,0.71 [0.33-1.51],0.3719039407881783
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21939,699,1.04 [0.90-1.21],0.5654311169907369
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22847,181,0.96 [0.71-1.30],0.7840468908433553
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23379,72,0.72 [0.40-1.30],0.2774991570185435
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23799,69,0.92 [0.55-1.54],0.7596441849771977
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23602,40,0.96 [0.50-1.84],0.9074260183825996
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23798,33,0.42 [0.15-1.16],0.0951927515884207
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Stomach,23836,27,0.73 [0.28-1.88],0.5126973948350642
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23573,259,0.88 [0.67-1.15],0.341414130514871
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23778,104,0.69 [0.42-1.13],0.136304450457798
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23782,79,1.20 [0.84-1.74],0.3190310116119811
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23751,41,0.74 [0.35-1.58],0.4349234748431958
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",23753,41,0.74 [0.35-1.58],0.4350332030104284
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,23654,202,0.99 [0.75-1.31],0.9702674164063106
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23801,91,0.88 [0.56-1.38],0.5754013261143844
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23716,159,0.63 [0.42-0.96],0.0310230394892999
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of breast,13147,81,0.81 [0.49-1.34],0.41455256215045
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,12857,594,0.94 [0.80-1.12],0.5060698813096672
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23000,166,0.97 [0.71-1.33],0.8439010572538252
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22884,300,1.09 [0.88-1.34],0.4487931349571233
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22884,300,1.09 [0.88-1.34],0.4487931349571233
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21831,304,1.00 [0.79-1.25],0.9663294949304916
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23410,69,1.38 [0.99-1.93],0.0565467889742071
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23618,84,1.09 [0.73-1.62],0.6661732042362986
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20878,606,0.91 [0.76-1.09],0.296741691347445
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22744,372,0.93 [0.74-1.16],0.516584464555049
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22264,86,0.83 [0.51-1.36],0.4702392561848095
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23171,50,0.80 [0.42-1.55],0.5171895681967669
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22253,75,0.86 [0.52-1.44],0.5729261066915488
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22456,278,1.02 [0.79-1.30],0.9017705517684712
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22449,271,1.04 [0.82-1.33],0.74642308336381
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22164,152,1.01 [0.72-1.41],0.9715938828559127
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22168,150,1.01 [0.72-1.42],0.9445847014108686
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20742,470,0.80 [0.64-1.00],0.0478334785105952
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20337,65,0.73 [0.39-1.36],0.318883018270055
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20706,434,0.78 [0.62-0.99],0.0392863357780294
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20311,39,0.64 [0.28-1.48],0.294147569112314
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20331,59,0.73 [0.38-1.38],0.3315964019801536
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,20668,661,0.90 [0.76-1.06],0.2163248724822392
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20268,261,0.85 [0.64-1.12],0.2398252140525866
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23473,198,0.90 [0.67-1.22],0.5012807705200361
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23525,144,1.00 [0.73-1.38],0.9802768217764132
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22130,68,0.69 [0.38-1.25],0.2168691719787614
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23740,68,0.71 [0.39-1.29],0.2611210865346985
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20075,68,0.69 [0.38-1.25],0.2193380393200357
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Alcohol dependence,22146,84,0.97 [0.65-1.45],0.8796907544470207
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,22096,61,0.60 [0.30-1.21],0.1531780231659902
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20077,70,1.08 [0.71-1.65],0.721670082235187
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20332,325,0.87 [0.68-1.11],0.253750740310618
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression,22344,282,0.88 [0.68-1.14],0.329434087956007
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Depression or dysthymia,20209,246,0.91 [0.69-1.19],0.4801068418487225
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20132,125,0.92 [0.64-1.34],0.6796851734486682
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22551,57,0.96 [0.56-1.66],0.8876718403545332
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,21213,1266,0.91 [0.80-1.03],0.1212631051910968
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19755,154,0.97 [0.71-1.34],0.8599965218367767
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23652,124,0.87 [0.59-1.29],0.4863890750520936
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22697,426,0.95 [0.78-1.16],0.6112873953914384
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,22419,148,0.97 [0.70-1.36],0.8788501925476545
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,22358,87,1.03 [0.68-1.55],0.897483317067508
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23517,77,1.14 [0.77-1.70],0.5093619583417703
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23414,35,1.30 [0.77-2.18],0.3246990239169078
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22419,148,0.82 [0.56-1.20],0.3095095782560292
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,113,0.87 [0.57-1.33],0.5231797545673371
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22859,530,0.88 [0.72-1.06],0.1820056188785298
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22450,121,0.88 [0.59-1.31],0.5265820958279773
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22614,285,0.99 [0.78-1.26],0.9521041641666064
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23657,76,0.75 [0.43-1.30],0.3002256096631512
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23631,50,0.92 [0.51-1.67],0.7831455724449413
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23459,108,1.13 [0.81-1.58],0.4762381994953321
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,274,0.92 [0.71-1.19],0.5081112613962288
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23303,147,0.91 [0.64-1.29],0.5830255885125974
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23235,79,1.08 [0.72-1.63],0.7131137593881686
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23244,88,0.81 [0.50-1.33],0.410403041815666
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23199,43,0.86 [0.44-1.69],0.6628965405970658
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22351,53,1.13 [0.70-1.84],0.6207263181069897
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22457,159,0.92 [0.66-1.29],0.6472961510550117
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23304,106,1.08 [0.76-1.54],0.6647662157549694
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23621,17,0.60 [0.16-2.18],0.4380468397846566
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1510,17,0.68 [0.20-2.36],0.5468725414225446
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22128,17,0.59 [0.16-2.18],0.4315194408220394
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23513,41,0.90 [0.46-1.75],0.7495316187037496
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23494,22,0.67 [0.23-1.99],0.4710237172341982
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23425,82,1.06 [0.70-1.61],0.7899195454288088
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23473,89,0.81 [0.50-1.32],0.4012609831120447
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23722,110,1.22 [0.89-1.66],0.2111815942642988
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23384,83,0.72 [0.42-1.24],0.2339439372184066
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18619,1701,0.93 [0.83-1.04],0.218090200950316
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23560,36,1.54 [1.04-2.26],0.0294542892086689
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19520,1142,0.96 [0.84-1.10],0.5568757105368247
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,19535,1157,0.95 [0.83-1.08],0.44042530797239
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18407,29,0.28 [0.09-0.91],0.0349299595169429
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22549,492,0.86 [0.70-1.05],0.1359800518463103
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,22355,298,0.94 [0.73-1.20],0.601188313480163
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23217,117,0.94 [0.64-1.39],0.7650145946884417
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23321,221,1.00 [0.76-1.31],0.983689672270982
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23739,51,0.73 [0.36-1.46],0.3705141919335488
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22195,138,0.90 [0.62-1.29],0.5599151221228881
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22417,368,0.76 [0.59-0.98],0.0364546068861081
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23392,75,1.12 [0.74-1.70],0.5905208832884447
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23395,158,1.24 [0.96-1.60],0.0987219291962583
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23376,59,1.43 [1.02-2.00],0.0365269887874122
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23377,60,1.43 [1.03-2.00],0.0342387851352352
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18434,56,1.50 [1.06-2.11],0.0210880051613579
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21582,40,0.68 [0.31-1.52],0.347685989769215
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,21608,66,1.20 [0.81-1.79],0.3588189640117483
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16219,80,1.03 [0.67-1.59],0.8887714945499811
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16311,172,1.05 [0.78-1.41],0.763013043761897
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21578,36,1.05 [0.56-1.95],0.8863899335979041
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21593,51,1.35 [0.91-1.99],0.136454486439273
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23402,109,0.93 [0.62-1.39],0.7136424126970539
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23370,97,0.54 [0.31-0.95],0.0322590785151843
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23400,73,0.63 [0.34-1.16],0.1354716707375639
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23442,63,0.75 [0.41-1.38],0.355538417836722
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23186,44,1.12 [0.66-1.88],0.6762953587475684
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23217,75,0.98 [0.62-1.56],0.946836505915124
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22786,104,1.30 [0.97-1.74],0.0816240819786867
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22769,87,1.44 [1.09-1.90],0.0101900179853742
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23697,84,1.45 [1.09-1.92],0.0098710010243589
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,23059,377,1.13 [0.94-1.36],0.1900303842871749
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,23208,42,1.07 [0.61-1.88],0.8103650043546836
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20173,1686,1.02 [0.92-1.13],0.7250498129617996
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23634,115,0.93 [0.63-1.37],0.6967569707191408
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22813,160,1.08 [0.80-1.45],0.6144729385898711
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22788,135,1.03 [0.73-1.44],0.877383643590283
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23296,194,1.03 [0.78-1.35],0.8563814234733056
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23295,193,1.03 [0.78-1.36],0.8439728175535309
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23069,568,1.06 [0.90-1.24],0.4887997367958292
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22588,87,1.24 [0.89-1.74],0.2009518916427973
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22595,94,0.90 [0.58-1.40],0.6416715667072521
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22862,361,1.07 [0.88-1.30],0.5005453157711848
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22691,190,1.17 [0.92-1.50],0.1974519922871026
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13685,41,1.06 [0.62-1.83],0.8233727621477339
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21813,767,0.97 [0.84-1.13],0.7059029633808639
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,23229,92,1.14 [0.79-1.66],0.48604855126637
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23229,92,1.14 [0.79-1.66],0.48604855126637
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23229,92,1.14 [0.79-1.66],0.48604855126637
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22317,692,0.96 [0.82-1.12],0.5728748945263602
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Asthma,18204,692,0.96 [0.81-1.13],0.5979547234907393
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18075,692,0.96 [0.81-1.12],0.5933587343127934
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18189,677,0.96 [0.81-1.13],0.6143957551725652
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23668,53,0.83 [0.44-1.54],0.5538560954818332
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22669,41,0.93 [0.49-1.78],0.8235185061030483
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23724,41,0.93 [0.48-1.77],0.8154246342267256
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22663,35,0.85 [0.41-1.80],0.6789708582855665
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,22672,67,0.93 [0.55-1.55],0.7702583023619125
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22761,156,0.89 [0.63-1.26],0.5144164246602259
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23101,71,1.09 [0.71-1.68],0.7054266429458309
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16926,4434,0.98 [0.91-1.05],0.5139706992913288
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23315,419,0.99 [0.82-1.21],0.948434530733542
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23771,119,0.83 [0.55-1.26],0.3798011839747707
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23776,110,0.86 [0.56-1.30],0.467058477816187
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,22997,101,1.23 [0.90-1.69],0.2009064537049166
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22988,92,0.98 [0.64-1.50],0.9238960362033574
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23758,133,0.88 [0.61-1.29],0.5166003078608619
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22971,75,0.74 [0.42-1.30],0.289799393451313
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22765,51,1.10 [0.66-1.82],0.7187308635751244
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23728,38,0.89 [0.44-1.79],0.7454032211167664
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19167,176,0.69 [0.47-1.01],0.0592597752205046
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20515,1524,0.94 [0.85-1.05],0.2994853362777044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,19224,233,0.80 [0.59-1.09],0.1581544210684788
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19483,492,0.92 [0.76-1.11],0.3814535778082806
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19048,57,1.46 [1.06-2.02],0.0223466461115211
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19112,121,0.90 [0.61-1.33],0.6095774327339374
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19015,24,nan [nan-nan],
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,19077,86,0.80 [0.48-1.32],0.3730935781257047
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19082,91,0.56 [0.32-0.99],0.0467567813762804
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,64,0.49 [0.24-0.99],0.0456793440908513
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,19086,95,0.73 [0.44-1.21],0.2200313712471764
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19544,553,0.87 [0.72-1.05],0.1507363820332029
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23673,138,1.07 [0.78-1.47],0.6908234865910899
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19334,343,0.97 [0.78-1.21],0.7837980878391961
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19085,94,0.99 [0.66-1.50],0.9700574842063304
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23665,171,1.03 [0.77-1.39],0.8187408101125463
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23643,108,1.03 [0.71-1.49],0.8657533615965208
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,21501,1018,0.93 [0.82-1.07],0.3060599158302015
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,20820,337,0.91 [0.72-1.15],0.4322264848082432
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,20583,100,1.16 [0.82-1.64],0.4158740513152633
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,20558,75,1.05 [0.68-1.61],0.8374720744083431
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21016,533,0.87 [0.72-1.06],0.1716140668498659
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23084,645,1.07 [0.92-1.24],0.3787130000184727
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,19614,1437,1.06 [0.95-1.17],0.2959628635719995
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23548,61,1.37 [0.96-1.96],0.0870628734734934
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23765,88,1.33 [0.97-1.81],0.0749045962822374
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,22527,88,1.32 [0.97-1.80],0.0779820081958456
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22507,68,1.22 [0.83-1.80],0.3110230139695825
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23715,114,1.07 [0.75-1.51],0.7099305544517951
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22553,114,1.07 [0.75-1.51],0.7158474419696461
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22536,97,1.06 [0.72-1.54],0.7725591756954215
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22958,519,1.02 [0.86-1.21],0.7868193706683166
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22954,515,1.02 [0.86-1.21],0.8057755082844542
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18235,58,0.98 [0.59-1.64],0.9389073131500716
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal stricture,23541,58,0.99 [0.59-1.67],0.9642770882124038
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18219,42,1.09 [0.64-1.88],0.7416867321343044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18438,261,1.31 [1.09-1.57],0.0034088951159727
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18322,145,1.07 [0.79-1.45],0.6713968371108655
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18388,211,1.07 [0.84-1.38],0.5727626452057839
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,22840,186,1.08 [0.82-1.41],0.5978881789745731
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23473,71,0.75 [0.43-1.33],0.3286279171191461
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18336,159,1.00 [0.73-1.36],0.9856790124398594
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18259,82,0.89 [0.56-1.43],0.6328899626927829
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18864,687,1.01 [0.87-1.17],0.8691170253172651
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18334,157,1.00 [0.74-1.37],0.9776146897646438
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23463,61,0.75 [0.40-1.38],0.3515909590486027
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,23201,105,1.06 [0.74-1.53],0.7482810340521404
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,23156,60,0.98 [0.58-1.65],0.9356034923684218
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22748,447,0.99 [0.82-1.20],0.9554296962543214
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,22658,357,0.89 [0.71-1.12],0.3312230213463367
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,22362,61,1.38 [0.97-1.96],0.0749574602090183
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22337,36,1.09 [0.60-1.99],0.7703312548263802
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22351,50,0.86 [0.46-1.60],0.6262199349651789
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23679,50,0.85 [0.45-1.60],0.6165202528091556
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22747,245,0.90 [0.69-1.19],0.4657796876720195
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22560,58,1.02 [0.61-1.69],0.9513595595682296
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,22549,47,1.11 [0.67-1.86],0.6840946022180019
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22538,36,1.21 [0.71-2.07],0.4761311656144702
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22658,156,0.78 [0.53-1.13],0.1926143921585356
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,22653,151,0.79 [0.54-1.15],0.2214991603359588
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21628,1280,0.98 [0.87-1.10],0.6940791328029725
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23503,87,0.95 [0.61-1.48],0.8175716150459114
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23475,404,0.91 [0.73-1.12],0.3784825822719169
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22881,453,0.99 [0.82-1.20],0.9199305173945016
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23156,354,0.95 [0.76-1.19],0.6619240840154823
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22897,95,0.97 [0.64-1.47],0.8729783201736754
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23002,200,0.94 [0.70-1.26],0.6752288944772831
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23611,72,1.18 [0.80-1.76],0.4074219064526672
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23598,59,1.18 [0.77-1.83],0.4473483479638628
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23581,42,0.94 [0.49-1.80],0.8557870411079669
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23695,27,0.84 [0.35-2.00],0.6922773958945252
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23692,24,nan [nan-nan],
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23127,56,0.67 [0.34-1.31],0.2405005041804415
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23379,308,0.96 [0.76-1.21],0.7521404936383085
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22487,59,0.86 [0.48-1.54],0.6111201206120684
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22509,81,0.97 [0.62-1.52],0.8898197105912724
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22498,70,0.85 [0.50-1.44],0.5410768564584052
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22605,177,1.04 [0.78-1.38],0.8106837029055523
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22583,155,0.99 [0.72-1.36],0.9550104309511585
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18452,3025,0.97 [0.90-1.05],0.4856738951946799
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19820,1610,0.94 [0.84-1.04],0.2401300430413944
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21717,944,1.03 [0.91-1.17],0.6256681662810908
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18322,112,1.25 [0.94-1.67],0.1218034000549565
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18514,304,0.94 [0.74-1.19],0.6127718090737948
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23543,107,1.25 [0.92-1.69],0.1525498792424987
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23555,95,1.26 [0.92-1.73],0.1444830096774376
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18782,572,0.95 [0.80-1.13],0.56957882597593
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20979,572,0.96 [0.81-1.15],0.6812221996155805
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18249,39,1.23 [0.75-2.04],0.4129118038995396
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23503,38,1.29 [0.78-2.13],0.3268077785394648
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18341,131,0.61 [0.38-0.97],0.0382566879276611
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18231,21,1.56 [0.97-2.51],0.0643472475771845
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18318,108,1.09 [0.77-1.55],0.6331038502498838
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23730,55,1.11 [0.68-1.81],0.6682899529220638
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18499,289,0.89 [0.69-1.15],0.3855691034130389
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18401,191,0.92 [0.68-1.26],0.615415478002287
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19270,1060,0.91 [0.80-1.04],0.1577097718909493
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18245,35,1.20 [0.69-2.08],0.5252165179092867
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18362,152,0.96 [0.69-1.33],0.7966305072685789
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18235,25,0.74 [0.28-1.96],0.5406445229796315
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18235,25,1.13 [0.56-2.27],0.7270129876096174
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18654,444,0.91 [0.74-1.11],0.3616966714776144
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18583,373,0.88 [0.70-1.10],0.2649556573275424
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18816,240,0.90 [0.68-1.19],0.4555910530428904
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23485,141,1.04 [0.76-1.43],0.7904917587895977
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23380,36,1.36 [0.87-2.14],0.178548260530938
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21272,44,0.85 [0.44-1.66],0.6388713936503974
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21426,198,0.82 [0.59-1.14],0.2352722088914184
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22015,787,0.99 [0.85-1.14],0.852576881545531
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21350,122,0.87 [0.58-1.30],0.4847256559235023
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21277,49,0.94 [0.52-1.70],0.846430779220389
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21888,660,1.02 [0.87-1.18],0.8409240935649818
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21276,48,0.53 [0.24-1.17],0.1144124447207727
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21454,226,1.01 [0.78-1.31],0.9375443084310467
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21329,101,0.98 [0.66-1.46],0.9367068344397478
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21286,58,1.28 [0.86-1.90],0.2246115753753633
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21348,120,1.11 [0.80-1.53],0.529370669632026
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21286,58,1.18 [0.76-1.82],0.465803418168415
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21512,284,1.04 [0.83-1.31],0.7213786572754508
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21016,243,1.06 [0.83-1.35],0.6457849001414051
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20818,45,0.95 [0.51-1.76],0.8643958748555458
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20816,43,0.81 [0.40-1.63],0.5499940974977833
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20875,102,1.20 [0.87-1.66],0.2558277530078908
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20824,51,0.60 [0.29-1.26],0.1783649802779388
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20826,53,0.71 [0.36-1.40],0.3266086921488105
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20814,41,0.73 [0.35-1.56],0.4209085027570037
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20958,185,1.04 [0.79-1.38],0.7616779789819103
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20817,44,0.89 [0.46-1.70],0.7150130781775363
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20816,43,0.89 [0.46-1.71],0.7182188274136803
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20864,91,1.22 [0.87-1.70],0.2464152383744733
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20838,65,0.87 [0.51-1.50],0.6242767268734644
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21149,376,1.05 [0.86-1.27],0.6520376349626282
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20904,131,1.12 [0.83-1.53],0.4530953448015553
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20969,196,0.95 [0.71-1.28],0.7400166951139113
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22635,92,0.89 [0.57-1.40],0.6245819530143428
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22836,293,0.96 [0.76-1.22],0.752284427719846
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22591,48,0.81 [0.42-1.57],0.5307571213647735
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22599,56,1.11 [0.68-1.80],0.6721779060838642
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22642,99,1.14 [0.81-1.63],0.4508038963454869
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20181,3780,0.99 [0.92-1.06],0.699062210635855
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9665,343,0.84 [0.65-1.08],0.1802643100045764
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22558,157,0.61 [0.40-0.93],0.0220852558161805
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22445,44,0.68 [0.32-1.45],0.3202990826970687
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22699,33,0.86 [0.40-1.84],0.7014246001565222
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22694,28,0.60 [0.22-1.64],0.3186544211168489
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22705,39,0.64 [0.28-1.47],0.2905572866061239
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23518,205,0.64 [0.44-0.92],0.0150061754960799
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23585,44,0.65 [0.30-1.42],0.2834278016016868
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23455,142,0.65 [0.42-1.01],0.0539469243359545
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23399,86,0.64 [0.37-1.12],0.1175959791946321
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22518,762,0.95 [0.81-1.10],0.4846651593283876
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,21824,68,0.87 [0.51-1.48],0.6017194831403136
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,0.43 [0.20-0.93],0.0329854534474873
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21912,156,0.83 [0.58-1.20],0.3186564048128142
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21836,80,0.75 [0.44-1.28],0.2945906010899028
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22291,535,1.01 [0.85-1.20],0.8873296259485278
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9381,59,0.57 [0.27-1.18],0.12816615341162
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9355,33,0.64 [0.25-1.64],0.3514595907873292
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9357,35,1.01 [0.52-1.98],0.969738483125076
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9394,72,0.93 [0.56-1.55],0.787226271753937
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9379,57,1.01 [0.60-1.71],0.9588317259941532
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9402,80,0.99 [0.63-1.56],0.9705702510047922
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13024,217,1.21 [0.97-1.50],0.0838885099711634
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12871,64,0.78 [0.44-1.39],0.3989294321136953
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12880,73,1.61 [1.24-2.09],0.0003700273649578
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12855,48,0.92 [0.51-1.66],0.7902767267289463
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12991,333,0.88 [0.70-1.12],0.2963461206926763
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12729,71,0.61 [0.33-1.13],0.1140765948268124
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12826,168,0.96 [0.71-1.31],0.8083711911645504
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11988,2391,1.00 [0.91-1.09],0.9343356444911672
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9847,250,0.89 [0.68-1.17],0.4036144358371725
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9676,79,1.09 [0.73-1.63],0.6639426175708205
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9694,97,0.59 [0.35-1.02],0.0587097263525147
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9864,267,1.03 [0.81-1.30],0.8211195525714589
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9861,264,0.84 [0.64-1.10],0.205244335586483
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10011,414,1.05 [0.87-1.26],0.6077228416607967
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9744,147,1.14 [0.87-1.51],0.3467533181477706
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9784,187,1.07 [0.83-1.40],0.5973158167109063
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9668,71,1.08 [0.71-1.65],0.7197427467667079
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9722,125,1.26 [0.97-1.64],0.0883744810061327
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13152,175,1.22 [0.96-1.55],0.0998030639095829
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13159,168,1.21 [0.94-1.55],0.1319998365245518
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13175,95,1.26 [0.92-1.73],0.1533505987271796
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13169,103,1.27 [0.94-1.71],0.119844721425869
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9657,60,1.12 [0.72-1.72],0.6160852640386705
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9650,53,1.05 [0.64-1.71],0.8428738938070218
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9657,60,1.22 [0.82-1.83],0.32450259393482
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13089,321,0.76 [0.58-0.99],0.039528061872911
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10583,986,0.91 [0.79-1.04],0.1727618415908927
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10272,675,0.89 [0.76-1.05],0.1829187225582395
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13163,138,0.88 [0.61-1.27],0.4948392026085429
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9898,301,0.98 [0.78-1.23],0.8714773860448446
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9823,226,0.93 [0.71-1.23],0.6218450692279498
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9828,231,1.03 [0.81-1.32],0.7990167248017663
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female infertility,9684,87,0.93 [0.59-1.47],0.7663489286915586
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9677,80,0.99 [0.64-1.55],0.980240320818588
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13169,723,0.82 [0.69-0.98],0.0271361046726638
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13176,988,0.94 [0.81-1.08],0.3833201840107199
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13171,383,1.12 [0.93-1.35],0.2333370100797028
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12897,109,0.82 [0.53-1.27],0.372476105659826
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12943,155,1.26 [0.98-1.63],0.0713510452939339
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12922,134,1.11 [0.82-1.52],0.4995605574319491
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13185,139,0.85 [0.58-1.23],0.3841728109099833
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13187,138,0.86 [0.59-1.25],0.4172406646464283
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13184,354,0.87 [0.68-1.10],0.233327176077018
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12933,103,0.97 [0.65-1.44],0.8863464790440202
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13030,200,0.92 [0.68-1.24],0.5641700282586014
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12569,123,0.96 [0.67-1.38],0.8319058932823218
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12614,168,0.98 [0.73-1.33],0.9129258440347856
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12648,202,0.93 [0.70-1.25],0.6397896390648701
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12571,125,0.95 [0.66-1.36],0.7687891862667179
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12561,115,0.94 [0.65-1.37],0.7461008231372379
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12565,119,0.63 [0.39-1.01],0.0537828164233977
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12379,191,0.78 [0.55-1.11],0.1715565945393924
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12550,362,0.79 [0.61-1.01],0.0650248108997997
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12738,550,0.95 [0.79-1.15],0.603055959855191
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13190,143,1.06 [0.78-1.45],0.7077505350717184
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,11990,110,1.06 [0.74-1.50],0.7639074306709416
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12269,81,0.88 [0.54-1.43],0.6169518066749726
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13195,277,1.11 [0.89-1.39],0.336705588494015
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13133,215,1.14 [0.89-1.45],0.2914896366005155
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13184,208,1.07 [0.83-1.39],0.6063610281783866
CASQ2,Calsequestrin-2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13174,198,1.10 [0.85-1.42],0.4752490349540269
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23619,32,0.74 [0.32-1.75],0.4981324571179172
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22420,446,0.99 [0.82-1.20],0.9420295280777752
